Impact of Subtype on Survival of Young Patients With Stage IV Breast Cancer
Authors:
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 19 (3) , 200-207.e1
Abstract
No abstract availableKeywords
Funding Information
- Puma Biotechnology
This publication has 22 references indexed in Scilit:
- Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer SurvivalJournal of Clinical Oncology, 2016
- Prognostic factors in patients with metastatic breast cancer at the time of diagnosisPathology - Research and Practice, 2014
- Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcomeBreast Cancer Research and Treatment, 2013
- Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancerBreast Cancer Research and Treatment, 2009
- Elevated Breast Cancer Mortality in Women Younger than Age 40 Years Compared with Older Women Is Attributed to Poorer Survival in Early-Stage DiseaseJournal of the American College of Surgeons, 2009
- Trends in Survival Over the Past Two Decades Among White and Black Patients With Newly Diagnosed Stage IV Breast CancerJournal of Clinical Oncology, 2008
- Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene ExpressionJournal of Clinical Oncology, 2008
- Factors influencing the effect of age on prognosis in breast cancer: population based study Commentary: much still to learn about relations between tumour biology, prognosis, and treatment outcome in early breast cancerBMJ, 2000
- Younger women with breast carcinoma have a poorer prognosis than older womenCancer, 1996
- Stage IV Breast CancerAmerican Journal of Clinical Oncology, 1988